212 related articles for article (PubMed ID: 10352302)
1. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.
Mullins DW; Burger CJ; Elgert KD
J Immunol; 1999 Jun; 162(11):6811-8. PubMed ID: 10352302
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation.
Mullins DW; Koci MD; Burger CJ; Elgert KD
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):473-92. PubMed ID: 9805229
[TBL] [Abstract][Full Text] [Related]
3. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth modulates macrophage nitric oxide production following paclitaxel administration.
Mullins DW; Burger CJ; Elgert KD
Int J Immunopharmacol; 1998 Oct; 20(10):537-51. PubMed ID: 9839658
[TBL] [Abstract][Full Text] [Related]
6. Hsp70 induces Th1 polarization through tumor-associated macrophages in a T-cell lymphoma.
Kumar S; Deepak P; Acharya A
Neoplasma; 2007; 54(2):113-22. PubMed ID: 17319783
[TBL] [Abstract][Full Text] [Related]
7. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell-derived TGF-beta and IL-10 dysregulate paclitaxel-induced macrophage activation.
Mullins DW; Martins RS; Burger CJ; Elgert KD
J Leukoc Biol; 2001 Jan; 69(1):129-37. PubMed ID: 11200057
[TBL] [Abstract][Full Text] [Related]
9. Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.
Mullins DW; Walker TM; Burger CJ; Elgert KD
Cancer Immunol Immunother; 1997 Oct; 45(1):20-8. PubMed ID: 9353423
[TBL] [Abstract][Full Text] [Related]
10. Post-chemotherapeutic administration of interleukin-12 retards tumor growth and enhances immune cell function: combination therapy using paclitaxel and IL-12.
Pressley JS; Elgert KD
Cancer Invest; 2006; 24(4):351-9. PubMed ID: 16777686
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-gamma is associated with the activation of extracellular signal-related kinase.
Zhu YN; Yang YF; Ono S; Zhong XG; Feng YH; Ren YX; Ni J; Fu YF; Tang W; Zuo JP
Int Immunol; 2006 Jun; 18(6):981-90. PubMed ID: 16636012
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2.
Wigginton JM; Kuhns DB; Back TC; Brunda MJ; Wiltrout RH; Cox GW
Cancer Res; 1996 Mar; 56(5):1131-6. PubMed ID: 8640772
[TBL] [Abstract][Full Text] [Related]
13. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition.
Alleva DG; Kaser SB; Monroy MA; Fenton MJ; Beller DI
J Immunol; 1997 Sep; 159(6):2941-51. PubMed ID: 9300718
[TBL] [Abstract][Full Text] [Related]
14. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma.
Alleva DG; Johnson EB; Lio FM; Boehme SA; Conlon PJ; Crowe PD
J Leukoc Biol; 2002 Apr; 71(4):677-85. PubMed ID: 11927655
[TBL] [Abstract][Full Text] [Related]
15. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
Alleva DG; Elgert KD
Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
[TBL] [Abstract][Full Text] [Related]
16. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
Tsung K; Dolan JP; Tsung YL; Norton JA
Cancer Res; 2002 Sep; 62(17):5069-75. PubMed ID: 12208763
[TBL] [Abstract][Full Text] [Related]
17. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
18. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages.
Kirikae T; Ojima I; Ma Z; Kirikae F; Hirai Y; Nakano M
Biochem Biophys Res Commun; 1998 Apr; 245(3):698-704. PubMed ID: 9588177
[TBL] [Abstract][Full Text] [Related]
19. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens.
Chelvarajan RL; Collins SM; Doubinskaia IE; Goes S; Van Willigen J; Flanagan D; De Villiers WJ; Bryson JS; Bondada S
J Leukoc Biol; 2004 Jun; 75(6):982-94. PubMed ID: 14982942
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP).
Shin HJ; Kim YS; Kwak YS; Song YB; Kim YS; Park JD
Planta Med; 2004 Nov; 70(11):1033-8. PubMed ID: 15549658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
